Ocrelizumab: A New Generation of anti‐CD20 mAbfor Treatment of Multiple SclerosisAndrew C. Chan,Paul Brunetta,Peter ChinSuccessful Drug Discovery(2019)引用 0|浏览4暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要